This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: Ozchela Inc.. Active years: 2022-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2024
Title: Jin-Kak Lee: Innovator in Stilbene Derivatives
Introduction
Jin-Kak Lee is a notable inventor based in Hwaseong, South Korea. He has made significant contributions to the field of chemistry, particularly in the development of stilbene derivatives. With a total of 3 patents to his name, Lee's work focuses on innovative methods that have the potential to impact medical treatments.
Latest Patents
One of Jin-Kak Lee's latest patents is centered around a stilbene derivative and the method for preparing it. This invention specifically relates to a novel stilbene derivative that inhibits the function of cyclophilin. The implications of this work are profound, as it is aimed at preventing cyclophilin-related diseases and treating their symptoms. The method of preparation is also a key aspect of this patent, showcasing Lee's expertise in both synthesis and application.
Career Highlights
Jin-Kak Lee is currently associated with Ozchela Inc., where he continues to push the boundaries of innovation in his field. His career is marked by a commitment to research and development, particularly in the area of chemical compounds that can lead to significant advancements in healthcare.
Collaborations
Lee collaborates with talented individuals such as Min-Kyung Lee and Won-Seok Han. These partnerships enhance the research environment and foster innovation, allowing for a diverse range of ideas and expertise to come together.
Conclusion
Jin-Kak Lee's contributions to the field of chemistry, particularly through his work on stilbene derivatives, highlight his role as an influential inventor. His ongoing research and collaborations promise to yield further advancements in the treatment of cyclophilin-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile